Omnicell Future Growth
Future criteria checks 3/6
Omnicell is forecast to grow earnings and revenue by 100.7% and 6% per annum respectively. EPS is expected to grow by 100.1% per annum. Return on equity is forecast to be 7.5% in 3 years.
Key information
100.7%
Earnings growth rate
100.1%
EPS growth rate
Medical Equipment earnings growth | 0% |
Revenue growth rate | 6.0% |
Future return on equity | 7.5% |
Analyst coverage | Good |
Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,230 | 33 | 62 | 154 | 5 |
12/31/2025 | 1,163 | 24 | 32 | 133 | 9 |
12/31/2024 | 1,105 | 8 | 38 | 144 | 9 |
9/30/2024 | 1,064 | -18 | 118 | 170 | N/A |
6/30/2024 | 1,080 | -21 | 152 | 204 | N/A |
3/31/2024 | 1,103 | -21 | 165 | 218 | N/A |
12/31/2023 | 1,147 | -20 | 126 | 181 | N/A |
9/30/2023 | 1,186 | -34 | 165 | 225 | N/A |
6/30/2023 | 1,235 | -23 | 127 | 189 | N/A |
3/31/2023 | 1,268 | -18 | 48 | 107 | N/A |
12/31/2022 | 1,296 | 6 | 17 | 78 | N/A |
9/30/2022 | 1,309 | 48 | -5 | 55 | N/A |
6/30/2022 | 1,258 | 61 | 18 | 77 | N/A |
3/31/2022 | 1,199 | 72 | 98 | 158 | N/A |
12/31/2021 | 1,132 | 78 | 173 | 232 | N/A |
9/30/2021 | 1,070 | 80 | 195 | 249 | N/A |
6/30/2021 | 987 | 60 | 194 | 242 | N/A |
3/31/2021 | 914 | 35 | 164 | 218 | N/A |
12/31/2020 | 892 | 32 | 131 | 186 | N/A |
9/30/2020 | 891 | 38 | 86 | 144 | N/A |
6/30/2020 | 906 | 49 | 101 | 164 | N/A |
3/31/2020 | 924 | 69 | 85 | 144 | N/A |
12/31/2019 | 897 | 61 | 83 | 145 | N/A |
9/30/2019 | 860 | 54 | 98 | 158 | N/A |
6/30/2019 | 836 | 48 | 59 | 117 | N/A |
3/31/2019 | 807 | 38 | 55 | 112 | N/A |
12/31/2018 | 787 | 38 | 50 | 104 | N/A |
9/30/2018 | 772 | 54 | 8 | 61 | N/A |
6/30/2018 | 754 | 48 | N/A | 27 | N/A |
3/31/2018 | 747 | 44 | N/A | 16 | N/A |
12/31/2017 | 713 | 31 | N/A | 25 | N/A |
9/30/2017 | 688 | -1 | N/A | 45 | N/A |
6/30/2017 | 678 | -6 | N/A | 72 | N/A |
3/31/2017 | 670 | -9 | N/A | 56 | N/A |
12/31/2016 | 696 | 10 | N/A | 50 | N/A |
9/30/2016 | 651 | 8 | N/A | 54 | N/A |
6/30/2016 | 599 | 14 | N/A | 40 | N/A |
3/31/2016 | 539 | 24 | N/A | 44 | N/A |
12/31/2015 | 485 | 31 | N/A | 38 | N/A |
9/30/2015 | 476 | 32 | N/A | 37 | N/A |
6/30/2015 | 463 | 32 | N/A | 50 | N/A |
3/31/2015 | 455 | 31 | N/A | 75 | N/A |
12/31/2014 | 441 | 31 | N/A | 65 | N/A |
9/30/2014 | 425 | 28 | N/A | 49 | N/A |
6/30/2014 | 407 | 29 | N/A | 59 | N/A |
3/31/2014 | 395 | 27 | N/A | 52 | N/A |
12/31/2013 | 381 | 24 | N/A | 55 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMCL * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (8.1%).
Earnings vs Market: OMCL * is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OMCL * is expected to become profitable in the next 3 years.
Revenue vs Market: OMCL *'s revenue (6% per year) is forecast to grow slower than the MX market (7.2% per year).
High Growth Revenue: OMCL *'s revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMCL *'s Return on Equity is forecast to be low in 3 years time (7.5%).